Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
Resource Type
Article
Authors
Phillips, Andrew N ; Bansi-Matharu, Loveleen ; Venter, Francois ; Havlir, Diane ; Pozniak, Anton ; Kuritzkes, Daniel R ; Wensing, Annemarie ; Lundgren, Jens D ; Pillay, Deenan ; Mellors, John ; Cambiano, Valentina ; Jahn, Andreas ; Apollo, Tsitsi ; Mugurungi, Owen ; Ripin, David ; Da Silva, Juliana ; Raizes, Elliot ; Ford, Nathan ; Siberry, George K ; Gupta, Ravindra K ; Barnabas, Ruanne ; Revill, Paul ; Cohn, Jennifer ; Calmy, Alexandra ; Bertagnolio, Silvia
Source
In The Lancet HIV March 2020 7(3):e193-e200
Subject
Primary Research Articles
Language
ISSN
2352-3018